Delota Corp.

C$0.07As of Sun 8 Nov 2026, 12:00 UTC

CSE:NICHealthcare

Country Canada

PE (Fwd) •••

TSR 7Y CAGR (21.19%)

Div yield —

ROE —

Pharmaceutical Retailers

Beta (5Y) 0.07

PE TTM —

TSR TTM (38.10%)

Mkt cap C$1.892M

ROIC —

SE Grade™

—

Value

Quality

Moat

Consensus

Reference

$0.0708

8.93%

60.26%

Hold 0|8|7|2|1

TTM

FYE 31 Mar CAD

FY2017

FY2018

FY2019

FY2020

FY2021

FY2022

FY2023

FY2024

FY2025

FY2026

FY2027E

Trend

5Y

10Y

Peers

0.456

Revenue$M

0.347

0.366

0.391

0.414

0.452

0.474

0.516

0.566

0.600

0.650

0.484

7.56%

7.05%

21

28.57

Revenue growth%

30.79

31.01

31.60

31.92

30.73

33.43

32.38

32.19

32.20

29.25

6.38

32.20

31.76

68

14.28

Gross margin%

34.70

37.59

37.28

34.79

35.51

38.08

38.45

37.40

35.88

38.50

27.45

38.08

37.34

10

22.30

Operating margin%

26.87

28.46

30.54

29.40

28.12

27.27

26.96

27.18

29.75

31.54

20.04

27.27

28.29

66

12.27

Net margin%

32.87

30.79

28.79

26.21

26.93

26.25

25.15

25.17

25.02

27.32

5.59

25.17

26.59

53

31.04

P/E ratio (avg)x

16.12

16.55

15.64

16.82

15.91

17.15

19.96

19.56

19.37

19.88

26.96

19.56

16.98

82

31.63

EV/EBITx

47.66

50.37

59.98

72.45

84.62

95.35

111.5

130.9

157.4

174.7

21.15

130.9

89.99

94

27.26

FCF yield (avg)%

0.72

3.34

1.43

2.22

4.07

5.93

4.16

1.81

1.20

2.92

15.21

2.92

2.57

36

6.58

FCF margin%

22.51

25.28

25.10

27.96

26.65

29.06

26.14

28.47

29.88

32.70

26.99

29.06

27.31

92

1.196

FCF / Net incomex

1.063

1.087

1.139

1.260

1.255

1.364

1.255

1.365

1.422

1.575

0.707

1.365

1.257

28

13.36

ROIC%

0.40

0.40

0.40

1.84

1.42

0.40

0.40

1.29

0.40

1.95

20.74

0.40

0.40

42

20.23

Return on equity%

10.80

10.13

12.40

10.88

9.93

8.29

6.99

5.40

4.20

5.56

22.01

5.56

9.11

66

27.20

Return on assets%

6.85

9.57

6.86

4.21

3.38

4.76

7.24

8.20

11.12

12.97

27.38

8.20

7.05

64

—

EPS$

—

—

—

—

—

—

—

—

0.01

0.01

—

9.57%

9.17%

—

11.14

EPS growth%

16.37

15.69

15.50

13.55

11.61

14.19

11.29

10.47

10.71

10.83

28.68

10.83

12.58

91

—

Bookvalue per sh$

0.01

—

0.01

0.01

0.01

0.01

0.01

0.01

0.01

0.01

0.01

(0.27%)

2.55%

—

—

FCF per share$

—

—

0.01

0.01

0.01

0.01

0.01

0.01

0.01

0.01

—

7.40%

6.47%

—

—

Dividend per sh$

0.01

0.01

0.01

0.01

0.01

0.01

0.01

0.01

0.01

0.01

—

(0.23%)

0.90%

—

11.24

Div yield (avg)%

29.21

31.62

30.17

29.54

27.52

28.16

30.67

30.00

31.46

33.78

16.24

30.67

30.09

20

20.51

Payout ratio%

0.40

0.40

0.40

0.40

0.40

2.16

0.40

0.40

1.33

0.40

14.52

0.40

0.40

40

29.14

Shares (diluted)M

37.18

42.96

44.08

51.42

60.32

61.37

60.95

67.71

76.36

76.96

29.00

4.99%

7.89%

77

2.85

Buyback yield%

0.40

0.40

0.40

0.40

0.40

2.17

4.63

7.51

7.17

7.96

27.50

7.17

1.29

70

1.742

D/E ratiox

1.094

1.166

1.226

1.323

1.444

1.432

1.502

1.507

1.418

1.280

1.454

1.432

1.370

61

0.507

Enterprise value$M

0.746

0.745

0.719

0.782

0.855

1.007

0.991

1.051

1.153

1.209

0.381

7.18%

5.35%

62

0.529

LT debt$M

0.056

0.049

0.048

0.049

0.045

0.044

0.038

0.039

0.041

0.039

0.341

(2.99%)

(2.83%)

48

Peers (US$1.339M)

Cap (US$)

PE

Century Global…

2.928M

—

Copland Road Capital…

1.388M

—

RAMM Pharma Corp.

1.268M

—

Global Uin Intelligenc…

1.392M

—

Capital

TTM

5Y

10Y

Leveragex

1.552

—

—

EBIT/Intx

0.487

1.011

0.998

Own earn%

62.59

(60.15)

(53.06)

Sh yield%

14.09

37.51

31.30

Owners

Insiders/Inst%

0.28

37.75

Short interest%

5.41

SBC / revenue%

3.78

Record

10Y

Profitable years

10/10

Revenue growth years

10/10

EPS growth years

10/10

Dividend streakyrs

23

Op margin range%

27–32

$1 testx

—

Incr. ROIC%

141

Growth vs revenue

Latest

Trend

10Y CAGR

Rel growth

Revenue

$0.650M

7.05%

1.00×

Cost of revenue

$0.390M

7.22%

1.02×

Operating expenses

$0.106M

6.47%

0.95×